Drug Approval | April 22, 2023
Ajinomoto Bio-Pharma receives FDA approval for high potency fill line
Aji Bio-Pharma has six fill finish lines located in San Diego, including a new line
Aji Bio-Pharma has six fill finish lines located in San Diego, including a new line
WuXi Bio provided technical services, based on the companies' versatile integrated service platforms, to support various manufacturing and process development activities of these ADC product candidates.
Prometheus Biosciences’ comprehensive data set enables target discovery and precision medicine approach in inflammation and immunology
The combination will support clients in getting their end-to-end discovery and development programs delivered.
India's strategy against Covid was more effective than any other countries in the world
Collaboration will enable rapid advancement of a joint preclinical proof of concept program for type 1 diabetes
Lonza supports development and manufacturing of ABL Bio’s bispecific antibody candidate with a complete and integrated end-to-end solution
The summit encompasses multiple verticals, spanning from pharmaceuticals, biotech, life sciences, and the Healthcare sector to ensure an unbiased and comprehensive view on the future of the function.
The disease is caused by a mutation in the gene encoding HMG CoA reductase, inhibiting the enzyme’s activity.
Subscribe To Our Newsletter & Stay Updated
